[go: up one dir, main page]

SI1589966T1 - Postopek čiščenja losartana - Google Patents

Postopek čiščenja losartana

Info

Publication number
SI1589966T1
SI1589966T1 SI200431599T SI200431599T SI1589966T1 SI 1589966 T1 SI1589966 T1 SI 1589966T1 SI 200431599 T SI200431599 T SI 200431599T SI 200431599 T SI200431599 T SI 200431599T SI 1589966 T1 SI1589966 T1 SI 1589966T1
Authority
SI
Slovenia
Prior art keywords
new
pharmaceutically suitable
losartan
preparation
forms
Prior art date
Application number
SI200431599T
Other languages
English (en)
Inventor
Ljubomir Antoncic
Anton Copar
Peter Svete
Breda Husu-Kovacecic
Zoran Ham
Boris Marolt
Original Assignee
Lek Pharmaceuticals D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SI200300025A external-priority patent/SI21423A/sl
Priority claimed from SI200300026A external-priority patent/SI21424A/sl
Priority claimed from SI200300145A external-priority patent/SI21508A/sl
Priority claimed from SI200300157A external-priority patent/SI21509A/sl
Application filed by Lek Pharmaceuticals D.D. filed Critical Lek Pharmaceuticals D.D.
Publication of SI1589966T1 publication Critical patent/SI1589966T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
SI200431599T 2003-01-30 2004-01-29 Postopek čiščenja losartana SI1589966T1 (sl)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
SI200300025A SI21423A (sl) 2003-01-30 2003-01-30 Priprava novih farmacevtsko uporabnih oblik losartana z novimi metodami čiščenja in izolacije
SI200300026A SI21424A (sl) 2003-01-30 2003-01-30 Postopek čiščenja losartana
SI200300145A SI21508A (sl) 2003-06-12 2003-06-12 Proces priprave tetrazolskih derivatov v novi kristalni obliki
SI200300157A SI21509A (sl) 2003-06-26 2003-06-26 Priprava tetrazolskega derivata v novi kristalni obliki
SI200300270 2003-11-05
EP04706411A EP1589966B1 (en) 2003-01-30 2004-01-29 Preparation of new pharmaceutically suitable salt of losartan and forms thereof with new purification and isolation methods
PCT/SI2004/000001 WO2004066997A2 (en) 2003-01-30 2004-01-29 Preparation of new pharmaceutically suitable salt of losartan and forms thereof with new purification and isolation methods

Publications (1)

Publication Number Publication Date
SI1589966T1 true SI1589966T1 (sl) 2011-06-30

Family

ID=32831169

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200431599T SI1589966T1 (sl) 2003-01-30 2004-01-29 Postopek čiščenja losartana

Country Status (6)

Country Link
US (1) US7271269B2 (sl)
EP (1) EP1589966B1 (sl)
AT (1) ATE487478T1 (sl)
DE (1) DE602004029982D1 (sl)
SI (1) SI1589966T1 (sl)
WO (1) WO2004066997A2 (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20032472A1 (it) * 2003-12-16 2005-06-17 Dinamite Dipharma S P A In Forma A Bbreviata Diph Procedimento per la preparazione di losartan potassio cristallino
EP1729766A1 (en) * 2004-03-01 2006-12-13 LEK Pharmaceuticals D.D. Pharmaceutical formulation
ITMI20050551A1 (it) * 2005-04-01 2006-10-02 Dipharma Spa Forma cristallina alfa di losartan potassio
CA2609026A1 (en) * 2005-05-18 2007-03-08 Combino Pharm, S.L. Formulations containing losartan and/or its salts
AU2006307470A1 (en) * 2005-10-27 2007-05-03 Lupin Limited Pharmaceutical formulation of losartan
ATE487711T1 (de) * 2005-12-01 2010-11-15 Ulkar Kimya Sanayii Ve Ticaret Verfahren zur herstellung von metallsalzen von losartan
WO2008018843A1 (en) * 2006-08-08 2008-02-14 Ulkar Kimya Sanayi Ve Ticaret As Process for producing useful salts form of biphenyl-tetrazole compounds
PE20081200A1 (es) 2006-12-04 2008-11-06 Bayer Schering Pharma Ag Sal de potasio cristalina de analogos de lipoxina a4
WO2013132511A1 (en) * 2012-03-09 2013-09-12 Hetero Research Foundation Novel polymorph of lurasidone hydrochloride

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100212257B1 (ko) * 1991-11-18 1999-08-02 미리암 디. 메코나헤이 Aii 수용체 길항물질을 합성하기 위한 테트라졸릴페닐보론산 중간체의 제조 방법
GB9406573D0 (en) * 1994-03-31 1994-05-25 Merck Sharp & Dohme Medicaments
SE9502219D0 (sv) * 1995-06-19 1995-06-19 Astra Ab Novel medical use
PT937068E (pt) * 1996-10-29 2002-07-31 Merck & Co Inc Processo para a cristalizacao de losartan
US5795904A (en) * 1996-12-06 1998-08-18 Merck & Co., Inc. Enhanced functional recovery of the heart by losartan treatment after an ischemic attach
JP2001226372A (ja) * 1999-12-06 2001-08-21 Sumika Fine Chemicals Co Ltd ロサルタンの結晶性または結晶化された酸付加塩およびロサルタンの精製方法
US7413751B2 (en) * 2001-10-25 2008-08-19 Depomed, Inc. Methods of treatment using a gastric retained losartan dosage
US20040097568A1 (en) * 2002-07-29 2004-05-20 Dr. Reddy's Laboratories Limited Crystalline form of losartan potassium

Also Published As

Publication number Publication date
US20060004207A1 (en) 2006-01-05
US7271269B2 (en) 2007-09-18
ATE487478T1 (de) 2010-11-15
EP1589966B1 (en) 2010-11-10
DE602004029982D1 (de) 2010-12-23
WO2004066997A2 (en) 2004-08-12
EP1589966A2 (en) 2005-11-02
WO2004066997A3 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
WO2005042516A3 (en) Ligands of melanocortin receptors and compositions and methods related thereto
MXPA03010877A (es) Derivados de 2-anilin-pirimida como inhibidores de cinasa dependientes de ciclina.
MX2007010072A (es) Derivados de piperidina antibacterianos.
CA2499330A1 (en) New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors
UA86776C2 (ru) Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и применение
UA84878C2 (ru) Производные 2-пиридона как ингибиторы нейтрофилов эластазы, фармацевтическая композиция на их основе, способ их получения
EG23719A (en) New process for the synthesis of (I S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane and addition salts thereof, and application in the synthesis of I V abradine and addition salts thereof witha pharmaceutically acceptable acid
WO2004113292A3 (en) Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them
UA101313C2 (uk) Щотижневе введення інгібіторів дипептидилпептидази
NZ596820A (en) Trans-4-[[(5s)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl] (2-methyl-2h-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1h-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
SI1589966T1 (sl) Postopek čiščenja losartana
WO2006040318A3 (en) Pi3 kinase gamma inhibitors for the treatment of anaemia
SE0301701D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
MXPA05013050A (es) Derivados de bencimidazol, composiciones que los contienen preparacion de los mismos y usos de los mismos.
MX2009008463A (es) Formulaciones biodisponibles de compuestos heterociclicos.
MXPA03010766A (es) Nuevos compuestos y composiciones como inhibicores de las catepsinas.
TW200633964A (en) Tetralin and indane derivatives and uses thereof
AU2003214386A1 (en) Pyrimidine compounds
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
WO2006113647A3 (en) Recovery of tissue function following administration of b cells to injured tissue
SI2139866T1 (sl) Kristalni 1-(cikloheksiloksikarboniloksi)etil 1-((2'-cianobifenil-4-il)metil)-2-etoksi-1H-benzo(d)imidazol- 7karboksilat in postopek za njegovo pripravo
SE0302571D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
TW200616635A (en) Novel compounds
WO2007017897A3 (en) Novel crystalline forms of (s)-n-(1-carboxy-2-methyl-prop-1-yl)-n-pentanoyl-n-[2'-(1h-tetrazol-5-yl)bi-phenyl-4-ylmethyl]-amine